• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of surgical oncology. Supplement

    Journal of surgical oncology. Supplement

    JournalISSN 1046-7416

    年发文量

    研究主题

    论文(11716)

    排序
    1Ewing's Sarcoma in Adults: A Predictive Nomogram and Survival Analysis of a Cohort of 937 Patients
    Jonathan Gibson, Ben Thompson, Katie Williams, Chuck Lam,Shashank Chapala, Morgan Jones,Rajesh Botchu

    BACKGROUND:Ewing sarcoma is a rare malignancy of bone and soft tissue that most commonly affects children, adolescents, and young adults. Although multimodal treatment has improved survival in localised disease, outcomes remain poorer in adults, particularly in those with metastatic disease, larger tumours, or anatomically complex primary sites. Current staging systems are useful for treatment allocation but do not fully capture individual prognostic variation. This study aimed to develop and internally validate a predictive nomogram for disease-specific survival in adult patients with Ewing sarcoma. METHODS:A retrospective population-based cohort study was performed using the SEER-17 database from 2000 to 2015. Adult patients aged 18 years or older with histologically confirmed primary Ewing sarcoma of bone or soft tissue were included. The primary outcome was disease-specific survival. Predictor variables included age, sex, tumour site, tumour size, metastatic status, surgery, radiotherapy, and chemotherapy. Multivariable Cox proportional hazards regression was used to identify independent prognostic factors and construct a nomogram estimating 1-, 3-, and 5-year disease-specific survival. Internal validation was performed using 150 bootstrap resamples, and clinical utility was assessed using decision curve analysis. RESULTS:A total of 937 adult patients were included. The mean age was 33.9 years, and 556 patients were male. Extraosseous disease was the most common primary site, followed by axial bone and appendicular bone disease. Metastatic disease was present in 294 patients. Multivariable analysis identified metastatic disease, increasing age, larger tumour size, and absence of surgery as independent adverse prognostic factors. The nomogram incorporated age, clinical stage, primary site group, tumour size, surgery, and chemotherapy to estimate 1-, 3-, and 5-year disease-specific survival. Internal validation demonstrated an optimism-corrected C-index of 0.688, with acceptable calibration across the three time points. Decision curve analysis suggested that the full nomogram provided greater clinical utility than stage alone across intermediate threshold probabilities. CONCLUSION:This study developed and internally validated a population-based prognostic nomogram for adult patients with Ewing sarcoma. The model demonstrated acceptable discrimination and calibration, and may support individualised risk assessment, prognostic communication, and clinical decision-making. External validation in independent cohorts, incorporating molecular and treatment-intensity data, is required to further improve clinical applicability.

    2026
    引用
    AI阅读
    加入学术空间
    2Fixing A Problem That May Not Exist: 3N2 + 1N1 Mandate Prioritizes Compliance over Safety
    Shubham Gulati,Raja Flores,Tara Ivic-Pavlicic,Matthew Untalan,Stephanie Tuminello,Emanuela Taioli,Brian Housman

    INTRODUCTION:In 2020, the American College of Surgeons introduced Operative Standard 5.8 mandating that lymph nodes be sampled from 1 hilar (N1) station and 3 separate mediastinal (N2) stations for all lung resections with curative intent. Though lymph node assessment is necessary for staging, there is limited data to define the number of lymph nodes or the extent of dissection. We seek to clarify modern trends in mediastinal lymph node sampling. METHODS:The SEER database was queried for patients who underwent surgery, 18 years and older, between 2018 and 2020 with non-small cell lung cancer. Demographics, stage, histology, and cause-of-death were compared. RESULTS:Of 17927 NSCLC patients, 16 431 (91.7%) underwent MLNS. Percentages increased over time 91% (2018), 92% (2019), and 93% (2020). MLNS was associated with more average harvested nodes (13.5 vs. 8.2), although the number of positive lymph nodes was similar. Death from any cause and lung cancer-specific death was higher in patients that did not receive MLNS (12.2% vs 9.1% and 7.8% vs 5.3%). CONCLUSION:MLNS is performed in more than 91% of anatomic resections. It is not known if each satisfied the 3N2 + 1N1 threshold with evidence strong enough to demand it. Operative Standard 5.8 mandates a solution for a problem that may not exist. Threatening hospitals with loss of accreditation distracts the surgeon agency with non-clinical considerations and compromises safe choices.

    2026
    引用
    AI阅读
    加入学术空间
    3Factors Associated with Receipt of Adjuvant Radiation in Locally Advanced Rectal Cancer.
    Maryam Sherwani,Danish Ali,Hanjoo Lee,Alexander T Hawkins,Aimal Khan

    BACKGROUND:Neoadjuvant radiotherapy (RT) has been the standard of care for locally advanced rectal cancer (LARC) for over two decades. Adjuvant RT use in LARC represents a deviation from standard care and warrants further investigation. OBJECTIVES:To identify factors associated with adjuvant RT utilization. We hypothesized that sociodemographic determinants contribute to differences in the sequence of radiation treatment among patients with rectal cancer. METHODS:This retrospective cohort study utilized the National Cancer Database (2015-2022) to identify adults with clinical stage II-III rectal adenocarcinoma undergoing surgery and RT. Patients were categorized by RT sequence (neoadjuvant vs. adjuvant). Multivariable logistic regression identified factors associated with use of adjuvant RT. RESULTS:Of the included 48 452 patients, 6.9% received adjuvant RT. Compared with the neoadjuvant group, adjuvant RT recipients exhibited higher rates of pathologic upstaging (20.5% vs. 10.3%), positive margins (14.7% vs. 6.3%), and lymphovascular invasion (17.4% vs. 11.3%; all p < 0.001). On multivariable analysis, positive margins (aOR 1.78, 95% CI 1.43-2.22), lymphovascular invasion (aOR 1.96, 95% CI 1.66-2.31), upstaging (aOR 1.63, 1.31-2.02) were independently associated with adjuvant RT. CONCLUSIONS:Adjuvant RT appeared to be used in patients who were found to have high-risk tumor pathology postoperatively.

    2026
    引用
    AI阅读
    加入学术空间
    4Treatment Selection and Survival in Muscle-Invasive Bladder Cancer: Real-World Data on the Impact of Geriatric-8 Screening.
    Gaku Okumura,Shugo Yajima, Erika Ikezoe,Shu Gozu,Naoki Imasato,Kohei Hirose,Madoka Kataoka,Yasukazu Nakanishi,Hitoshi Masuda

    AIM:Standard treatment for muscle-invasive bladder cancer (MIBC) includes radical cystectomy (RC), a highly invasive procedure. We evaluated the utility of the Geriatric-8 (G8) screening tool in guiding treatment and whether the survival benefit of RC differs by G8 score. METHODS:We retrospectively reviewed patients with non-metastatic MIBC who underwent G8 assessment (2020-2024). Patients were grouped by G8: low (<11), intermediate (11-14), and high (>14). Treatment patterns and the effectiveness of RC were evaluated. RESULTS:A total of 152 patients were included (high: n = 55, intermediate: n = 67, low: n = 30). RC was performed in 124 patients (81.6%). Lower G8 was linked to older age, poorer performance status, and dependent instrumental activities of daily living (p < 0.01). Neoadjuvant chemotherapy followed by RC was more frequently planned in the high G8 group (81.8% vs. 53.7% vs. 26.7%, p < 0.0001), while immediate RC was a more common plan in the low G8 group (14.5% vs. 41.8% vs. 53.3%, p = 0.0003). RC was associated with significantly improved overall survival, and the benefit persisted after propensity score matching (p = 0.0013). Inverse probability of treatment weighting, which retained the whole cohort, gave a consistent estimate (hazard ratio [HR] 0.17, 95% confidence interval [CI] 0.08-0.39). Subgroup estimates were less precise in the low G8 group (HR 0.57, 95% CI 0.12-2.73) than in the intermediate (HR 0.14, 95% CI 0.06-0.33) and high (HR 0.10, 95% CI 0.02-0.39) groups. In sliding window analysis, HR estimates were higher at G8 < 9, with wide CIs. Similar results were observed for cancer-specific survival. CONCLUSIONS:RC was associated with a survival benefit in patients with intermediate and high G8 scores, whereas the evidence in the low G8 group was limited and inconclusive; careful risk-benefit evaluation remains warranted in this group.

    2026
    引用
    AI阅读
    加入学术空间
    5The Impact of Advanced Age on Functional Recovery Following Glossectomy.
    Jenny Chen, Ayana Cole-Price, Brianna M Peet,Kyeong-Tae Lee,Geoffrey E Hespe,Lillian A Boe,Louise Cunningham,Farooq Shahzad,Marc A Cohen,Jennifer R Cracchiolo,Jonas A Nelson,Evan Matros,

    BACKGROUND:Glossectomy for oral cancer can lead to significant concerns regarding speech and swallowing function. This study aims to assess the impact of age on post-glossectomy functional recovery and quality of life. METHODS:We conducted a retrospective analysis of patients who underwent glossectomy for primary oral cavity cancer involving the oral tongue from 2016 to 2024. Patients were stratified into three cohorts: < 60, 60-70, and > 70 years. Functional outcomes were assessed using speech-language pathology evaluations at 1 month, 6 months, 1 year, and 2 years postoperatively. Patient-reported quality of life was assessed using FACE-Q scores. RESULTS:206 patients were included, with 92 patients under 60, 61 patients aged 60-70, and 53 patients over 70. Primary closure was performed in 80 patients (39%), and free flap reconstruction in 109 (53%). One month postoperatively, patients over 70 demonstrated significantly higher rates of moderate to severe reductions in labial ROM and strength (p < 0.05). At 1 and 2 years, most functional differences had resolved, but deficits in labial ROM and strength persisted at 2 years (p = 0.048). FACE-Q scores, gastrostomy tube and tracheostomy dependence, length of stay, readmission, reoperation, and revision rates did not differ across cohorts. When adjusting for comorbidities, glossectomy type and age were significant predictors of long-term functional outcomes. CONCLUSION:Older patients undergoing glossectomy may experience initial delays in functional recovery, but long-term clinically meaningful functional outcomes are comparable across age groups. However, older patients may experience decreased patient-reported satisfaction in key domains, emphasizing the need for careful patient selection and shared decision-making when considering glossectomy in older adults.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 11716 篇论文

    高被引作者

    作者引用发文
    JA SPRATT41774
    John S. Spratt39061
    Pippa Simpson39061
    Timothy M Pawlik3141119
    Marcello Deraco248339
    Dario Baratti233231
    Shishir Maithel230990
    Shigeki Kusamura229933
    Robert C.G. Martin214740
    George A. Poultsides199275

    高产作者

    作者引用发文
    Timothy M Pawlik3141119
    Shishir Maithel230990
    George A. Poultsides199275
    Sugimachi K179259
    Ryan C. Fields137159
    Constantine Petros Karakousis122756
    Ming-Huei Cheng90045
    Kenneth Cardona86241
    David A. Kooby99241
    Robert C.G. Martin214740

    相关期刊

    Chirurgie; memoires de l'Academie de chirurgie
    Nowotwory
    Magyar sebeszet
    Current Colorectal Cancer Reports
    Journal of pancreatic cancer
    Gaceta Mexicana de Oncologia
    Surgery, Gastroenterology and Oncology
    Colon and Rectum
    Ejso
    Korean Journal of Clinical Oncology